Below are the most recent publications written about "Neoplasms" by people in Profiles.
-
Chow R, Zhang D, Chai GW, Yuen M, Lu A, Fortuna V, Talwar S, Boldt G, Lock M, Lee SF, Eng L, Iihara H, Affronti ML, Saito M, Aapro M, Hesketh PJ, Scott? F, Ruhlmann CH, Leigh J. Olanzapine (10?mg vs 5?mg vs 2.5?mg) for the prophylaxis of chemotherapy-induced nausea and vomiting (CINV) - a systematic review and network meta-analysis. Support Care Cancer. 2026 Jul 16; 34(8).
-
DiLillo KM, Forconi CS, Matta A, Melo J, McNamara RP, Tonui R, N'juguna F, Otieno JA, Odwar B, Kinyua A, Lauffenburger DA, Moormann AM. Estimating SARS-CoV-2 exposure in asymptomatic hospitalized children with cancer in Western Kenya: A retrospective analysis of serological data. PLoS One. 2026; 21(7):e0353284.
-
Kim JS, Lee WT, Keam B, Sim JA, Yoo SH. Association between the timing of palliative care consultation and end-of-life outcomes in patients with cancer. Support Care Cancer. 2026 Jul 10; 34(8).
-
Lee E, Karagenova R, Fuksman L, Katyal P, Lim T, Sun V, Reynolds KL, Semenov YR. Evaluating the safety of Janus kinase inhibitors in the management of severe immune-related adverse events. J Immunother Cancer. 2026 Jun 19; 14(6).
-
Ketelut-Carneiro N, Mathur A, Fitzgerald KA. Licensed to pore: Gasdermins in action. Cell Chem Biol. 2026 Jul 16; 33(7):982-1004.
-
West SM, Meyer MRU, Patterson C, Ruffin MT, Calo W, Pagoto S, Conroy D, Doerksen S, Sciamanna CN, Gordon B, Garrow G, Werts-Pelter SJ, Schmitz KH. Increasing physical activity in rural Pennsylvanians: The PA moves trial study protocol for a cluster randomized controlled trial. Contemp Clin Trials. 2026 Jul; 166:108348.
-
Sim JA, Yu J, Bae J, Seo JW, Kim JH, Yoo SH, Keam B. Temporal association of palliative care consultation with the trajectory of broad-spectrum antibiotic use at the end of life in advanced cancer: A nationwide linked cohort study. Int J Infect Dis. 2026 Aug; 169:108779.
-
Kim HJ, Sim JA, Lee SY, Yoo SH. Association between palliative care consultation and care transition outcomes among hospitalized advanced cancer patients. JNCI Cancer Spectr. 2026 May 09; 10(3).
-
Sim JA, Kim D, Yoo SH, Cho W, Hwang IY, Lee SY, Kim KH, Kim MS, Kim YJ, Jung EH, Lee J, Cho B. Social Capital and Financial Toxicity in Caregivers of Patients With Advanced Cancer: Associations With Health-Related Quality of Life and Psychological Distress. J Natl Compr Canc Netw. 2026 May; 24(5):155-162.
-
Johnson ML, Patel MR, Falchook GS, Koyama T, Gutierrez M, Awad MM, Piha-Paul SA, Friedman CF, Satoh T, Okamoto N, Singh J, Yoshizuka N, Windish HP, Qian M, Tran BP, Doi T. Ifinatamab deruxtecan, a B7-H3-directed antibody-drug conjugate, in patients with advanced solid tumours (IDeate-PanTumor01): dose-escalation results from a phase 1/2 trial. Lancet Oncol. 2026 Apr; 27(4):491-501.